Fluvoxamine
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292013This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O4L1XPO44W. European Medicines Agency schedules Fluvoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07769MIG. Fluvoxamine generally arises in the molecular formula C15H21F3N2O2. The term FLUVOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) FLUVOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluvoxamine under HS 29280090 and SITC 51486. As of Q4 2014, FLUVOXAMINE remains the US FDA Preferred Term for this commodity. Fluvoxamine bears US NLM identifiers UMLS ID C0085228 and NCI Concept Code C61769. SMILES: FC(F)(F)c1ccc(C(=N\OCCN)\CCCCOC)cc1.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.